U.S Pouches to 2016

This study analyzes the US market for pouches. It presents historical demand data for the years 2001, 2006 and 2011, and forecasts for 2016 and 2021 by type (stand-up, flat), market (food and beverage packaging, nonfood packaging), feature (aseptic, resealable, retort, shaped, spouted, stick and vacuum) and production method (form/fill/seal, preformed). The study also reviews market environment factors, assesses the industry structure, evaluates company market share and profiles industry players.

US demand to reach $8.8 billion in 2016
Demand for pouches in the US is projected to reach $8.8 billion in 2016, driven by above average gains for standup pouches stemming from sustainability, functional, and marketing advantages over alternative packaging media. Burgeoning consumer acceptance of pouches over rigid containers will buoy demand, as will such advantages as superior aesthetic appeal, portability, light weight, reduced material use, and significantly lower shipping costs than rigid containers. In addition, heightened use of reclosing and dispensing components will increase the competitiveness of pouches against rigid containers.

Solid prospects forecast for stand-up pouches
Solid prospects for stand-up pouches will be based on heightened interest among packaged goods companies due to savings achieved in shipping costs as a result of the lighter weight and lower material use of stand-up pouches compared to rigid containers. Also supporting gains will be the ability of stand-up pouches to differentiate products on store shelves due to their use of high-quality graphics, and the perception of pouches as a more contemporary packaging than cans, bottles and cartons.
In flat pouches, above average growth for four-side-seal pouches will be driven by rising demand in medical and pharmaceutical markets and in food applications such as meat, poultry, and seafood; and cheese. Flat pouch advances will also be supported by improved barrier structures and the incorporation of such convenience features as resealable closures, spouts, and tear notches. Additionally, opportunities for flat pouches will benefit from a rapidly expanding market for stick packs with single-portion packages of products such as drink mixes, sugar, sweeteners, coffee, protein powders, and pharmaceuticals. Moreover, the differentiation attributes of stick packs will promote opportunities in product line extensions and in refreshing or repositioning mature products.

Get your copy of this report @ http://www.reportsnreports.com/reports/175685-pouches.html 

Report Details:
Published:July 2012
No.of pages:331
Price: US$4900



Spouted pouches to be fastest growing by feature
Spouted pouches are expected to log double-digit growth, driven by expanding use of pouches in general, along with the functionality and convenient dispensing afforded by spouts. Processed foods applications will experience robust advances based on the growing popularity of baby food and children’s fruit snacks in spouted pouches and conversions from rigid containers in sauces and condiments. Good opportunities are also expected in the beverage market as spouted pouches further penetrate alcoholic beverages, premixed cocktails, sports drinks, and energy drinks.

Stand-up pouches to pace food & beverage markets
Food and beverage markets accounted for 79 percent of pouch demand in 2011 and will expand in line with the overall industry average. Faster growth is expected for stand-up pouches, reflecting cost, performance, and aesthetic advantages. Additionally, advances will be fueled by heightened demand for largersized pouches, spouted pouches, and pouches that use self-venting films to enable steam cooking of contents in the package. The excellent aesthetics of stand-up pouches are important in product marketing as the surfaces of stand-up pouches offer large billboard space suitable for eye-catching printing and graphics, particularly in grocery stores and similar venues where customers make rapid purchasing decisions.

COMPANY PRO FILES
Profiles more than 35 US industry players such as Amcor, American Packaging, Ampac Packaging, Bemis, Exopack, Printpack, Sealed Air, and Sonoco

Additional Information
This study analyzes the pouch packaging industry in the US. Product segments covered include flat (e.g., pillow, four-side-seal, and three-side-seal) and stand-up pouches employed in food, beverage, and nonfood applications. Also discussed are resealable, vacuum, retort, shaped, aseptic, stick, and spouted pouches (most of which can be produced in flat or stand-up varieties). Excluded from the scope of the study are bags and sacks, as well as nonpackaging pouch applications and air cushioning pouch packaging systems.
Historical data (2001, 2006, and 2011) and forecasts to 2016 and 2021 are provided for pouch demand (including merchant and captive production) in dollars by product type and market. Unit demand is presented for the overall market and for the food and beverage, and nonfood markets. “Demand” (or sales, apparent consumption) is defined as all shipments from US plants plus imports, minus exports. The term “shipment” includes production from all US manufacturing establishments that is shipped to both US and foreign markets.
In addition, the key strategic and competitive variables affecting the US pouch industry are discussed, and the industry’s key players are identified and profiled. US market share is also presented. The entire study is framed within the context of overall economic conditions, as well as developments and technologies affecting the pouch industry and its end users.

Table Of contents

INTRODUCTION

I. EXECUTIVE SUMMARY

II. MARKET ENVIRONMENTGeneral
Macroeconomic Outlook
Demographic Trends
Consumer Income & Spending
Retail Sales
Manufacturing Outlook
Food & Beverage Industry Overview
Packaging Industry Overview
Paper
Plastic
Metal
Glass & Wood
Pricing Trends
Machinery Trends
Raw Material & Component Trends
Plastic Film, Paper, & Foil
Adhesives, Inks, & Coatings
Closures & Other Components
Environmental & Regulatory Issues
International Activity & Foreign Trade

III. PRODUCT & MARKET OVERVIEWPouch Definition
Product Types
Flat Pouches
Pillow (Back Seal)
Markets
Product Characteristics
Four-Side-Seal
Markets
Product Characteristics
Three-Side-Seal
Markets
Product Characteristics
Stand-Up Pouches
Markets
Product Characteristics
Product Features
Resealable Pouches
Vacuum Pouches
Retort Pouches
Shaped Pouches
Aseptic Pouches
Stick Pouches
Spouted Pouches
Markets & Production Methods
Form/Fill/Seal
Preformed

IV. FOOD & BEVERAGE PACKAGINGGeneral
Candy & Snack Foods
Candy & Snack Food Outlook
Pouch Demand
Savory Snacks
Candy & Confections
Bakery Snacks
Nuts & Dried Fruit
Other
Processed Foods
Processed Foods Outlook
Pouch Demand
Dry Foods
Frozen Foods
Sauces & Condiments
Other Processed Foods
Fresh Produce
Fresh Produce Outlook
Pouch Demand
Beverages
Beverage Outlook
Pouch Demand
Juices & Fruit Drinks
Other Beverages
Meat, Poultry, & Seafood
Meat, Poultry, & Seafood Outlook
Pouch Demand
Pet Food
Pet Food Outlook
Pouch Demand
Cheese
Cheese Outlook
Pouch Demand
Other

V. NONFOOD PACKAGINGGeneral
Medical & Pharmaceutical
Medical & Pharmaceutical Products Outlook
Pouch Demand
Pharmaceuticals
Medical Supplies & Instruments
Consumer Products
Lawn & Garden Products
Wipes
Soaps & Cleaning Products
Other
Industrial & Other Products

VI. INDUSTRY STRUCTUREGeneral
Merchant vs. Captive
Market Share
Acquisitions & Divestitures
Competitive Strategies
Manufacturing
Marketing & Distribution
Cooperative Agreements
Company Profiles
Accredo Packaging, see Advance Polybag
Advance Polybag Incorporated
Amcor Limited
American Packaging Corporation
Ampac Packaging LLC
Barry-Wehmiller Companies Incorporated
Bemis Company Incorporated
Berry Plastics Corporation
Bosch (Robert) GmbH
Catalent Pharma Solutions Incorporated
CDF Corporation
Cheer Pack North America, see CDF
Cloud Packaging Equipment, see Ryt-way Industries
Coesia SpA
Curwood, see Bemis
DuPont (EI) de Nemours
Exopack Holding Corporation
Graphic Packaging Holding Company
HayssenSandiacre, see Barry-Wehmiller Companies
Hudson-Sharp Machine, see Barry-Wehmiller Companies
Illinois Tool Works Incorporated
InterFlex Group Incorporated
KHS USA, see Salzgitter
LPS Industries Incorporated
Milprint, see Bemis
Multifilm Packaging Corporation
Nordenia International AG
North State Flexibles, see St. John’s Packaging
Oliver Products Company
Oracle Packaging Incorporated
OYSTAR Holding GmbH
Perfecseal, see Bemis
PouchTec Industries LLC
Printpack Incorporated
Prolamina Corporation
Reynolds Group Holdings Limited
Robbie Manufacturing Incorporated
Rollprint Packaging Products Incorporated
ROVEMA GmbH
Ryt-way Industries LLC
SaddleSprings Beverage Company Incorporated
Salzgitter AG
Sealed Air Corporation
Sonoco Products Company
St. Johns Packaging Limited
Star Packaging Corporation
Totani Corporation
United Drug plc
Valley Packaging Industries Incorporated
Volpak USA, see Coesia
Wihuri Oy
Winpak, see Wihuri
Zip-Pak, see Illinois Tool Works
Other Companies Mentioned in Study

List Of Tables
SECTION I -- EXECUTIVE SUMMARY
Summary Table
SECTION II -- MARKET ENVIRONMENT
1 Macroeconomic Indicators
2 Population & Households
3 Personal Consumption Expenditures
4 Retail Sales
5 Manufacturers’ Shipments
6 Food & Beverage Shipments
7 Packaging Supply & Demand
8 Pouch Prices
SECTION III -- PRODUCT & MARKET OVERVIEW
1 Pouch Demand by Type
2 Flat Pouch Demand
3 Pillow Pouch Demand
4 Four-Side-Seal Flat Pouch Demand
5 Three-Side-Seal Flat Pouch Demand
6 Stand-Up Pouch Demand
7 Resealable Pouch Demand
8 Vacuum Pouch Demand
9 Retort Pouch Demand
10 Shaped Pouch Demand
11 Aseptic Pouch Demand
12 Stick Pouch Demand
13 Spouted Pouch Demand
14 Pouch Demand by Market, Production Method, & Appearance
SECTION IV -- FOOD & BEVERAGE PACKAGING
1 Food Packaging Pouch Demand by Application & Type
2 Candy & Snack Shipments
3 Candy & Snack Market for Pouches
4 Savory Snack Market for Pouches
5 Candy & Confection Market for Pouches
6 Bakery Snack Market for Pouches
7 Nut & Dried Fruit Market for Pouches
8 Other Snack Food Market for Pouches
9 Processed Foods Shipments
10 Processed Foods Market for Pouches
11 Dry Foods Market for Pouches
12 Frozen Foods Market for Pouches
13 Sauces & Condiments Market for Pouches
14 Other Processed Foods Market for Pouches
15 Fresh Produce Shipments
16 Fresh Produce Market for Pouches
17 Beverage Shipments
18 Beverage Market for Pouches
19 Juice & Fruit Drink Market for Pouches
20 Other Beverage Markets for Pouches
21 Meat, Poultry, & Seafood Shipments
22 Meat, Poultry, & Seafood Market for Pouches
23 Pet Food Shipments
24 Pet Food Market for Pouches
25 Cheese Market for Pouches
26 Other Foods Market for Pouches
SECTION V -- NONFOOD PACKAGING
1 Nonfood Packaging Pouch Demand by Application & Type
2 Medical & Pharmaceutical Product Shipments
3 Medical & Pharmaceutical Market for Pouches
4 Pharmaceutical Market for Pouches
5 Medical Supply & Instrument Market for Pouches
6 Consumer Products Market for Pouches
7 Industrial & Other Markets for Pouches
SECTION VI -- INDUSTRY STRUCTURE
1 US Merchant Pouch Sales by Company, 2011
2 Captive & Merchant Pouch Demand
3 Selected Acquisitions & Divestitures
4 Selected Cooperative Agreements

List Of Charts

SECTION III -- PRODUCT & MARKET OVERVIEW
1 Flat Pouch Demand by Type, 2011
2 Pillow Pouch Demand by Market, 2011
3 Four-Side-Seal Flat Pouch Demand by Market, 2011
4 Three-Side-Seal Pouch Demand by Market, 2011
5 Stand-Up Pouch Demand by Market, 2011
6 Pouch Features Comparison, 2001-2021
SECTION IV -- FOOD & BEVERAGE PACKAGING
1 Food Packaging Pouch Demand by Application, 2011
SECTION V -- NONFOOD PACKAGING
1 Nonfood Packaging Pouch Demand by Application, 2011
SECTION VI -- INDUSTRY STRUCTURE
1 US Merchant Pouch Market Share, 2011

Global and China Carbon Fiber Industry 2012 Deep Research Report

2012 Deep Research Report on Global and China Carbon Fiber Industry was a professional and depth research report on Global and China Carbon Fiber Industry. Firstly the report describes the background knowledge of Carbon Fiber, including Carbon Fiber Concepts Classification applications manufacturing process and cost structure; then statistics Global and China 22 Manufacturers Carbon Fiber Capacity production cost price production value profit margins and other relevant data, statistics these enterprises Carbon Fiber products, customers, raw materials, company background information, then summary statistics and analysis the relevant data of these enterprises. and get Global and China Carbon Fiber companies production market share, Small-tow (≤24K) large tow (>24K) Carbon Fiber production market share,Japan Europe United States China etc regional Carbon Fiber production market share, Polyacrylonitrile (PAN) base asphalt base Carbon Fiber production market share. Global and China Carbon Fiber demand supply and shortage, Global and China Carbon Fiber 2009 -2015 production price cost profit production value profit margins, etc. At the same time, we analyzed and discussed supply and demand changes in Carbon Fiber market and business development strategies, conduct a comprehensive analysis on China Carbon Fiber industry trends.In a word, It was a depth research report on Global and China Carbon Fiber industry. And thanks to the support and assistance from Carbon Fiber industry chain related experts and enterprises during Research Team survey and interview

PDF: 2000 USD ; Global License: 4000USD ; Pages: 90 ; Tables and Figures: 141 ; Published Date : Jul 13, 2012

 

   Table of Contents for this report include:  Chapter One Carbon Fiber Industry Overview 1
1.1 Carbon Fiber Industry Overview 1
1.1.1 Definition 1
1.1.2 Carbon Fiber Structure and Characteristic 2
1.1.3 Industry Chain 3
1.1.4 Carbon Fiber Industry Overview 4
1.2 Classification and Application 5
1.2.1 Classification 5
1.2.2 Application 7

Chapter Two Carbon Fiber Manufacturing Process 8
2.1 Raw Materials 8
2.2 Carbon Fiber Manufacturing Technology 9
2.2.1 Manufacturing Process 9
2.2.2 Key Manufacturing Equipments 12
2.3 Carbon Fiber Cost Analysis 16
2.3.1 Cost Structure 16
2.3.2 Cost Development Trend 17

Chapter Three Carbon Fiber Application Analysis 18
3.1 Carbon Fiber Applications 18
3.1.1 Aviation 18
3.1.2 Industry 20
3.1.3 Sports Products 20
3.1.4 Wind Energy 22
3.1.5 Automotive 22
3.2 Product Features Requirements of Different Use 23
3.2 Technical Requirements of Different Use 25

Chapter Four Carbon Fiber Manufacturing Cost Analysis 26
4.1 Raw Materials Cost Analysis 26
4.2 Process Cost Analysis 27
4.3 1000T/Year Pan Base Carbon Fiber Project Capex Analysis 27

Chapter Five Carbon Fiber Key Suppliers 28
5.1 Japan Companies 28
5.1.1 Toray(Japan Small-tow large-tow) 28
5.1.2 Toho Tenax(Japan Small-tow large-tow) 32
5.1.3 Mitsubishi Rayon (Japan Small-tow) 35
5.1.4 Japan Nippon Carbon (Japan Small-tow) 37
5.2 United States Companies 39
5.2.1 Hexcel(United States Small-tow) 39
5.2.2 Cytec Industries(United States Small-tow) 41
5.2.3 Zoltek (United States large-tow) 43
5.3 Europe Companies 45
5.3.1 SGL Carbon(Germany large-tow) 45
5.3.2 Carbon Fibre Technologies Ltd(United Kingdom large-tow) 47
5.3.3 Argon Ltd(Russia Small-tow) 49
5.4 Chinese Companies 51
5.4.1 Formosa Plastics Corporation (Taiwan) 51
5.4.2 Zhongfu Shenying Carbon FiberCo.,Ltd (China Small-tow) 53
5.4.3 Dalian Sinke (China Small-tow) 55
5.4.4 Sinosteel Jinlin Carbon (China Small-tow) 57
5.4.5 Weihai Tuozhan Fiber (China Small-tow) 59
5.4.6 Jiaxing Sino-Dia Carbon Fibre(China Small-tow) 62
5.4.7 Jiyan High-Tech(China Small-tow) 64
5.4.8 Zhongheng New Materials (China Small-tow) 65
5.4.9 SINOCARB(China Small-tow) 67
5.4.10 Jiangsu Hengshen(China Small-tow) 69
5.4.11 Henan Yongmei(China Small-tow) 71
5.4.12 Zhejiang Juxin (China Small-tow) 73

Chapter Six Carbon Fiber Market Outlook 75
6.1 Global and China Different Use Carbon Fiber Demand 75
6.2 Price Trend 76
6.3 Manufacturers Capacity Production and Market Share 77
6.4 Supply Demand and Development Trend (2009~2015) 89

Tables and Figures

Figure Carbon Fiber Picture 1
Table Different Type Carbon Fiber Mechanical Properties 2
Table Carbon Fiber and Metal Materials Key Performance Comparison 3
Figure Carbon Fiber Industry Chain Structure (Pan Base Carbin Fiber) 3
Table Carbon Fiber Small-tow (≤24K) large-tow (>24K) Classification and Applications List 5
Table Carbon Fiber PAN-base and Asphalt-base Carbon Fiber Classification and Applications List 6
Table PAN-base and Asphalt-base Carbon Fiber Specifications 6
Table Carbon Fiber HTS UTS IMS HMA UMS Steel Performance Comparison 6
Table Carbon Fiber Classification and Applications List 7
Table Carbon Fiber Raw Materials List 9
Table Global PAN Base Carbon Fiber Precursor Manufacturing Method List 10
Figure PAN Base Carbon Fiber Manufacturing Process Flow 10
Figure Asphalt Base Carbon Fiber Manufacturing Process Flow 11
Figure Viscose Fiber Carbon Fiber Manufacturing Process Flow 12
Figure External Heating Type Pre-oxidization Furnace Diagram 12
Figure Low Temperature Carbonization Furnace Structure 13
Figure 100Ton Carbon Fiber Product Line Structure 13
Figure High Temperature Carbonization Furnace Structure 14
Figure Tamm Type Graphitization Furnace Structure 15
Figure Plasma Graphitization Furnace Structure 15
Figure High Frequency Graphitization Furnace Structure 16
Table Carbon Fiber Cost Structure 16
Figure Carbon Fiber Aviation Applications Sample 18
Table Japan Toray Aviation Use Carbon Fiber Product Speficiations 19
Table 2009-2015 Global Aviation Use Carbon Fiber Demand (Ton) and Growth Rate 19
Table 2009-2015 Global Industry Use Carbon Fiber Demand (Ton) and Growth Rate 20
Table Sports Products Use Carbon Fiber Pictures 21
Table Mainusage and performance of Carbon Fibers 21
Table 2009-2015 Global Sports Products Use Carbon Fiber Demand (Ton) and Growth Rate 21
Table 2009-2015 Global Wind Energy Use Carbon Fiber Demand (Ton) and Growth Rate 22
Table Automotive Use Carbon Fiber Pictures 23
Table 2009-2015 Global Automotive Use Carbon Fiber Demand (Ton) and Growth Rate 23
Table Product Features Requirements of Different Use Carbon Fiber 23
Table Technical Problems of Different Use Carbon Fiber 25
Table Carbon Fiber Precursor Cost Structure(10KRMB/Ton) 26
Table Carbon Fiber Manufacturing Process Cost (10K RMB/Ton) (1 Ton Carbon Fiber Consume 2.2Ton Precursor) 27
Table 1000Ton/Year PAN Base Carbon Fiber Project Feasibility Analysis 27
Table Toray Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 28
Table Toray Carbon Fiber Products Specifications List 29
Table 2012 Capacity of TORAYCA® Carbon Fibers 30
Table 2009-2015 Japan Toray Carbon Fiber(Small-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 30
Figure 2009-2015 Toray Carbon Fiber(Small-tow) Capacity Production (Ton) and Growth Rate 31
Table 2009-2015 Japan Toray Carbon Fiber(large-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 31
Figure 2009-2015 TorayCarbon Fiber(large-tow) Capacity Production (Ton) and Growth Rate 32
Table Toho Tenax Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 32
Table Toho Tenax Product Specifications List 33
Table 2009-2015 Toho TenaxCarbon Fiber(Small-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 33
Figure 2009-2015 Toho TenaxCarbon Fiber(Small-tow) Capacity Production (Ton) and Growth Rate 34
Table 2009-2015 Toho TenaxCarbon Fiber(large-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 34
Figure 2009-2015 Toho TenaxCarbon Fiber(large-tow) Capacity Production (Ton) and Growth Rate 35
Table Mitsubishi Rayon Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 35
Table Mitsubishi Rayon Product Specifications List 36
Table 2009-2015 Mitsubishi Rayon Carbon Fiber(Small-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 37
Figure 2009-2015 Mitsubishi Rayon Carbon Fiber(Small-tow) Capacity Production (Ton) and Growth Rate 37
Table Japan Nippon Carbon Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 38
Table 2009-2015 Japan Nippon Carbon Carbon Fiber(Small-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 38
Figure 2009-2015 Japan Nippon Carbon Carbon Fiber(Small-tow) Capacity Production (Ton) and Growth Rate 39
Table Hexcel Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 39
Table Hexcel Product Specifications List 40
Table 2009-2015 HexcelCarbon Fiber(Small-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 41
Figure 2009-2015 HexcelCarbon Fiber(Small-tow) Capacity Production (Ton) and Growth Rate 41
Table Cytec Industries Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 42
Table 2009-2015 Cytec IndustriesCarbon Fiber(Small-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 42
Figure 2009-2015 Cytec IndustriesCarbon Fiber(Small-tow) Capacity Production (Ton) and Growth Rate 43
Table Zoltek Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 43
Table Zoltek Panex35 Product Specifications List 44
Table 2009-2015 ZoltekCarbon Fiber(large-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 44
Figure 2009-2015 ZoltekCarbon Fiber(large-tow) Capacity Production (Ton) and Growth Rate 45
Table SGL Carbon Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 45
Table 2009-2015 SGL Carbon Carbon Fiber(large-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 46
Figure 2009-2015 SGL Carbon Carbon Fiber(large-tow) Capacity Production (Ton) and Growth Rate 47
Table Carbon Fibre Technologies Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 47
Table 2009-2015 Carbon Fibre Technologies Ltd(United Kingdom)Carbon Fiber(large-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 48
Figure 2009-2015 Carbon Fibre Technologies Ltd(United Kingdom)Carbon Fiber(large-tow) Capacity Production (Ton) and Growth Rate 49
Table Russia Argon Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 49
Table 2009-2015 Russia Argon Carbon Fiber(Small-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 50
Figure 2009-2015 Russia Argon Carbon Fiber(Small-tow) Capacity Production (Ton) and Growth Rate 50
Table Formosa Plastics Corporation Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 51
Table Formosa Plastics Corporation Product Specifications List 52
Table 2009-2015 Formosa Plastics Corporation Carbon Fiber(Small-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 52
Figure 2009-2015 Formosa Plastics Corporation Carbon Fiber(Small-tow) Capacity Production (Ton) and Growth Rate 53
Table Zhongfu Shenying Corporation Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 53
Table 2009-2015 Zhongfu Shenying Product Specifications List 54
Table 2009-2015 Zhongfu Shenying Carbon Fiber(Small-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 54
Figure 2009-2015 Zhongfu Shenying Carbon Fiber(Small-tow) Capacity Production (Ton) and Growth Rate 55
Table Dalian Sinke Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 55
Table 2009-2015 Dalian Sinke Carbon Fiber(Small-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 56
Figure 2009-2015 Dalian Sinke Carbon Fiber(Small-tow) Capacity Production (Ton) and Growth Rate 57
Table Sinosteel Jinlin Carbon Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 57
Table 2009-2015 Sinosteel Jinlin Carbon Carbon Fiber(Small-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 58
Figure 2009-2015 Sinosteel Jinlin Carbon Carbon Fiber(Small-tow) Capacity Production (Ton) and Growth Rate 59
Table Weihai Tuozhan Fiber Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 59
Table Weihai Tuozhan Fiber PAN Base High Performance Special Carbon Fiber Product Specifications List 60
Table Weihai Tuozhan Fiber Product Specifications List 61
Table 2009-2015 Weihai Tuozhan Fiber Carbon Fiber(Small-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 61
Figure 2009-2015 Weihai Tuozhan Fiber Carbon Fiber(Small-tow) Capacity Production (Ton) and Growth Rate 62
Table Jiaxing Sino-Dia Carbon Fibre Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 62
Table 2009-2015 Jiaxing Sino-Dia Carbon FibreCarbon Fiber(Small-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 63
Figure 2009-2015 Jiaxing Sino-Dia Carbon FibreCarbon Fiber(Small-tow) Capacity Production (Ton) and Growth Rate 63
Table Jiyan High-Tech Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 64
Table 2009-2015 Jiyan High-Tech Carbon Fiber(Small-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 65
Figure 2009-2015 Jiyan High-Tech Carbon Fiber(Small-tow) Capacity Production (Ton) and Growth Rate 65
Table Zhongheng New Materials Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 66
Table 2009-2015 Zhongheng New Materials Carbon Fiber Products Specifications List 66
Table 2009-2015 Zhongheng New Materials Carbon Fiber Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 67
Figure 2009-2015 Zhongheng New Materials Carbon Fiber Capacity Production (Ton) and Growth Rate 67
Table SINOCARB Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 68
Table 2009-2015 SINOCARB Carbon Fiber(Small-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 68
Figure 2009-2015 SINOCARB Carbon Fiber(Small-tow) Capacity Production (Ton) and Growth Rate 69
Table Jiangsu Hengshen Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 69
Table 2009-2015 Jiangsu Hengshen Carbon Fiber Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 70
Figure 2009-2015 Jiangsu Hengshen Carbon Fiber Capacity Production (Ton) and Growth Rate 71
Table Henan Yongmei Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 71
Table 2009-2015 Henan Yongmei Carbon Fiber(Small-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 72
Figure 2009-2015 Henan Yongmei Carbon Fiber(Small-tow) Capacity Production (Ton) and Growth Rate 72
Table Zhejiang Juxin Company Information Table (Product Specifications,Applications,Manufacturing Base,Capacity,Market Position,Contact Information etc 13 Items) 73
Table 2009-2015 Zhejiang Juxin Carbon Fiber(Small-tow) Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 73
Figure 2009-2015 Zhejiang Juxin Carbon Fiber(Small-tow) Capacity Production (Ton) and Growth Rate 74
Table 2009-2016 Global and China Carbon Fiber Market Needs (Ton) of Different Uses 75
Figure Global Carbon Fiber Demand Market Share of Different Uses 76
Figure Global and China Carbon Fiber Demand Comparison 76
Table 2009-2015 Global Small-tow Carbon Fiber Capacity Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 76
Table 2009-2015 Global large-tow Carbon Fiber Capacity Production (Ton) Cost Price Profit (10K RMB/Ton) Production Value (10K RMB) Profit Margin List 77
Table 2009-2015 Global 22 Manufacturers Carbon Fiber Capacity and Total Capacity (Ton) List 77
Table 2009-2015 Global 22 Manufacturers Carbon Fiber Capacity Market Share List 78
Table 2009-2015 Global 22 Manufacturers Carbon Fiber Production and Total Production (Ton) List 79
Table 2009-2015 Global 22 Manufacturers Carbon Fiber Production Market Share List 80
Figure 2009-2015 Global Carbon Fiber Capacity Production and Growth Rate 82
Figure 2009-2015 Global Carbon Fiber Capacity Utilization Rate 82
Table 2009-2015 Global 19 Manufacturers Small-tow Carbon Fiber Capacity and Total Capacity (Ton) List 82
Table 2009-2015 Global 19 Manufacturers Small-tow Carbon Fiber Capacity Market Share List 83
Table 2009-2015 Global 19 Manufacturers Small-tow Carbon Fiber Production and Total Production (Ton) List 84
Table 2009-2015 Global 19 Manufacturers Small-tow Carbon Fiber Production Market Share List 85
Figure 2009-2015 Global Small-tow Carbon Fiber Capacity Production and Growth Rate 86
Table 2009-2015 Global 5 Manufacturers large-tow Carbon Fiber Capacity and Total Capacity (Ton) List 86
Table 2009-2015 Global 5 Manufacturers large-tow Carbon Fiber Capacity Market Share List 87
Table 2009-2015 Global 5 Manufacturers large-tow Carbon Fiber Production and Total Production (Ton) List 87
Table 2009-2015 Global 5 Manufacturers large-tow Carbon Fiber Production Market Share List 88
Figure 2009-2015 Global Large-tow Carbon Fiber Capacity Production and Growth Rate 88
Table 2009-2015 Global Japan USA China Europe Regional Carbon Fiber Production (Ton) and Market Share List 89
Table 2009-2015 Global Carbon Fiber Supply Demand and Shortage (Ton) List 89 Buy your copy of this report @ http://www.reportsnreports.com/reports/175710-2012-deep-research-report-on-global-and-china-carbon-fiber-industry.html.  

Market Growth Outlook in the Food and Beverage Industry - 2012–2013: Survey Brief

This report is the result of an extensive survey drawn from Canadean’s exclusive panel of leading food and beverage industry executives. It analyzes how demand and growth expectations are set to change in the food and beverage industry in 2012–13. The report also provides access to information categorized by company type, company turnover, buyer, supplier and region.

Weak economic growth in developed nations forced key food and beverage companies to expand their operations in developing regions especially, the Asia-Pacific, Brazil, and the Middle Eastern regions. As a result, food and beverage companies are viewing emerging economies not only as production locations, but as chief customer bases for future growth. Respondents were asked, ‘Which emerging markets do you expect to offer your industry the majority growth over the next 12 months?’ Responses have been categorized by different stakeholder categories to identify the specific growth regions for each.

Global food manufacturer respondents consider China and India to offer the largest growth potential among emerging markets over the next 12 months. Furthermore, the Middle East and Brazil are identified as the other emerging markets with the most potential for growth in 2012.

 Global F&B Industry: Top Five Emerging Markets, 2012

China represents the largest consumers of food products, mainly consisting of pork, corn, beef, and ready to eat food. A significant increase in household income, possibility of reduction in food prices due to ease of agri commodity prices, and changes in consumer attitude towards processed and healthy foods are factors that are expected to spur food consumption in China. Identifying these opportunities, many companies have expressed plans to expand their food processing and manufacturing capabilities in the country. For example, in February 2012, China's chief food company Uni-President Enterprises announced that it plans to invest US$100 million to build a factory in Jiangsu province in China. The new 40,000ft² factory will be built in two phases to increase production of pudding based products and instant noodles.

Reasons to buy

• Helps you to drive revenues by understanding market growth.

• Allows you to uncover the business outlook, demand in emerging markets and growth expectations in developed countries identified by suppliers and buyers.

• Access the opinions and forward looking statements of 210 industry executives, of which 29% represent Director and C-level respondents.

• The geographical scope of the research is global – drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.

• This report covers data and analysis on demand in emerging markets and growth expectations in developed countries.


Contact Sales@reportsandreports.com for further information.

Polymethyl Methacrylate (PMMA) Market By Application, Grade & Form - Global Trends & Forecasts (2012 – 2017)

Polymethyl Methacrylate (PMMA) is a transparent thermoplastic and impact resistant substitute of glass. It has good impact resistant, weather resistant and chemical resistant properties. It is light in weight, rigid and has color versatility. PMMA is used in various applications across automotive, electronics, construction, signs and displays, sanitary ware, lighting fixtures and other industries. Signs and display is a major market with largest consumption of PMMA followed by construction industry. Asia-Pacific is the largest geographic market and accounts for more than half of PMMA consumption. It is also the largest producer of PMMA. The second largest market is Europe followed by North America.

During global economic crisis PMMA market faced a decline in demand. In 2010 and 2011, the industry recovered from recession and registered significant growth. The estimated consumption of PMMA reached 1.67 million tones in 2011 globally. A boom light guided panel (LGP) based LCD screen market is one of the major drivers for this material.

Japan based Mitsubishi Rayon (including Lucite) is the largest supplier of PMMA. Some of the other major suppliers/manufactures are France based Arkema SA, South Korea’s LG MMA, Taiwan’s Chi Mei Corp., Germany’s Evonik Industries, and Japan based Sumitomo Chemical Company Ltd and Kuraray.

Methyl methacrylate (MMA) the key raw material and BASF, LG MMA, Arkema, Chi Mei, Dow Chemicals, Evonik, Mitsubishi Rayon and Sumitomo Chemicals are the major suppliers of MMA. In first half of 2011, industry faced short supply of MMA which restricted the supply of PMMA. Now both MMA and PMMA manufacturers are expanding their capacities to meet the future PMMA demand. Companies are also investing highly on R&D activities to develop better PMMA products. This will not only increase PMMA penetration in existing applications but also broaden the range of applications.

Get your copy of this report @ http://www.reportsnreports.com/reports/175336-polymethyl-methacrylate-pmma-market-by-application-grade-form-global-trends-forecasts-2012-2017-.html

Report Details:
Published: July 2012
No. of Pages: 294
Price: Single User License: US$4650 Corporate User License: US$7150



The report covers the major PMMA applications market which includes signs & displays, construction, automotive, lightning fixtures, electronics, and sanitary ware. The major on goings in the global PMMA are analyzed with respect to market drivers, opportunities, and winning imperatives related to the industry.

Based on the grade, the global PMMA market is segmented into general purpose and optical grade. PMMA market is majorly dominated by general purpose grade PMMA which accounted for 59.1% of the global PMMA market by consumption and the rest of the PMMA market is covered by optical grade PMMA.

The PMMA market share has been analyzed by taking into consideration the production capacity of major players of PMMA market which includes Arkema SA (France), LG MMA (South Korea), Chi Mei Corp. (Taiwan), Sumitomo Chemical Company Ltd (Japan), Evonik Industries (Germany), Mitsubishi Rayon (Japan), and Quinn Plastics (U.K.). These companies are also analyzed with respect to their products and competitive development in the past few years along with future speculations. The major competitive developments in these companies involved are product developments, agreements, joint ventures, and plant capacity expansions. The study PMMA price in different geographical regions along with PMMA prices for Asia based companies has also been discussed in this report.

The report also profiles the major players mentioned above with respect to their business, products, developments, financials, strategies, and other company specific information. This gives a brief idea about the areas in which company is progressing and the expansion and penetration, the company has been able to gain within the PMMA industry.

The global PMMA application market is also segmented with respect to different geographical regions including North America, Europe, Asia, and ROW. The study analyzes the application market for these regions as well and gives market value with respect to consumption and revenue for different PMMA applications. Asia-Pacific region is the largest market for PMMA with an estimated 40% of global market revenue share in 2011 and is estimated to reach $4.49 billion by 2017. The market is further segmented with respect to geographic break down which includes China, Japan, South Korea, India, U.S., Canada, Mexico, Germany, U.K., France, Spain, and Italy.

Markets Covered

The key markets covered in the global PMMA market are by application, grade and geography.

Grade type:

• General Purpose Grade
• Optical Grade

Applications:

• Signs and Displays
• Construction
• Automotive
• Lighting Fixtures
• Sanitary Ware
• Electronics

Stakeholders:

• PMMA Manufacturers
• PMMA Suppliers
• Electronics and Semi-conductor Companies
• Sanitary Ware Companies
• Automotive Manufacturers
• Automotive Component Suppliers
• Panels and Screens Manufacturers
• Raw Material Suppliers

The Global Military Aviation MRO Market 2012–2022

The global economic slowdown has reduced the defense budgets of most leading spenders in the world, including the US, France, Germany, and the UK. These countries have cut back their spending on various defense sectors such as space, aircraft, and military vehicles. However, these budget cuts have propelled the military aviation MRO industry as countries now prefer to maintain, repair and upgrade their existing fleet instead of buying new equipment. High growth markets such as India and China have been formulating continuous programs to enhance their military aviation MRO sector, with the US too focusing on maintaining their existing fleet. This trend is also evident from the fact that even a small market like Africa is expected to show positive growth during the forecast period.

Global Military Aviation MRO Market (US$ Billion), 2012–2022

The last decade has witnessed wars in Iraq, Afghanistan, Serbia and Libya which were primarily carried out by aerial attacks. Countries have been relying primarily on air power because it enables them to respond quickly to distant threats while putting relatively few lives at risk. However, this constant use has resulted in rapid aging and wearing out of the military aircraft fleet of the US and coalition allies, who are now spending considerably on their maintenance, repair and upgrading. The US, which is the highest spender on military MRO globally, is currently facing a combined problem of the rising age of many of its combat aircraft and delays to the F-35A fighter aircraft fleet. In spite of budget cuts and with a view of mitigating these problems, the government has decided to increase its spending on military aircraft MRO. Moreover, global spending is also expected to increase as the worldwide military fleet will only get older and the cost of replacing them is far greater than the cost of their MRO.

Reasons to buy

· Obtain detailed analysis of the market for military aviation MRO during 2012–2022, including the factors that influence why countries are investing or cutting defense expenditure. It provides detailed expectations of growth rates and projected total expenditure.

· Includes analysis on the main providers in the industry: Lockheed Martin, Boeing, BAE Systems, DynCorp International, Pratt & Whitney, Honeywell International, EADS, SAAB, Thales, Northrop Grumman, General Dynamics, Raytheon, Elbit Systems, Rolls Royce, Embraer SA.

Get your copy of this report @ http://www.reportsnreports.com/reports/175367-the-global-military-aviation-mro-market-2012-2022.html  

Report Details:
Published: July 12
No.of Pages: 178
Price: Single User License: US$4800        Corporate User License: US$ 14400

Infectives Partnering Terms and Agreements

The Infectives Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the infectives partnering deals and agreements entered into by the worlds leading healthcare companies.

• Trends in infectives partnering deals
• Average deal terms for headline, upfront and royalty by stage of development
• Infectives partnering agreement structure
• Infectives partnering contract documents
• Top infectives deals by value
• Most active infectives dealmakers

The Infectives Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the infectives partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter infectives partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors infectives technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This report contains over 2,000 links to online copies of actual infectives deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

Get your copy of this report @ http://www.reportsnreports.com/reports/175335-infectives-partnering-terms-and-agreements.html

Report Details:
Published: July 2012
No. of Pages: 804
Price: US$ 3695



The initial chapters of this report provide an orientation of infectives dealmaking and business activities. Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in infectives dealmaking since 2007 covering trends by year, deal type, stage of development, technology type and therapeutic indication. In addition the chapter includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. Analysis includes median values and distribution of values for each stage of development.

Chapter 3 provides a review of the leading infectives deals since 2007. Deals are listed by headline value, signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of infectives deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Chapter 5 provides comprehensive access to all infectives deals since 2007 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all infectives partnering deals signed and announced since 2007. The chapter is organized by specific infectives therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all infectives partnering deals signed and announced since 2007. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in infectives partnering and dealmaking since 2007.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of infectives technologies and products.

Report scope

Infectives Partnering Terms and Agreements is intended to provide the reader with an in-depth understanding and access to infectives trends and structure of deals entered into by leading companies worldwide.

• Infectives Partnering Terms and Agreements includes:
• Trends in infectives dealmaking in the biopharma industry since 2007
• Analysis of infectives deal structure
• Access to headline, upfront, milestone and royalty data
• Access to hundreds of infectives deal contract documents
• Comprehensive access to over 2,000 infectives deal records
• The leading infectives deals by value since 2007
• Most active infectives dealmakers since 2007

In Infectives Partnering Terms and Agreements, available deals and contracts are listed by:

• Headline value
• Upfront payment value
• Royalty rate value
• Stage of development at signing
• Deal component type
• Technology type
• Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Infectives Partnering Terms and Agreements report provides comprehensive access to available deals and contract documents for over 2,000 infectives deals. Analyzing actual contract agreements allows assessment of the following:

• What are the precise infectives rights granted or optioned?
• What is actually granted by the agreement to the partner company?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How aresalesand payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are IPRs handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes to be resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Infectives Partnering Terms and Agreements provides the reader with the following key benefits:

• In-depth understanding of infectives deal trends since 2007
• Access infectives deal headline, upfront, milestone and royalty data
• Research hundreds of actual contracts between infectives partner companies
• Comprehensive access to over 2,000 links to actual infectives deals entered into by the world’s biopharma companies
• Indepth review of infectives deals entered into by the leading fifty bigpharma companies
• Benchmark the key deal terms companies have agreed in previous deals
• Identify key terms under which companies partner infectives opportunities
• Uncover companies actively partnering infectives opportunities

Infectives Partnering Terms and Agreements

The Infectives Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the infectives partnering deals and agreements entered into by the worlds leading healthcare companies.

• Trends in infectives partnering deals
• Average deal terms for headline, upfront and royalty by stage of development
• Infectives partnering agreement structure
• Infectives partnering contract documents
• Top infectives deals by value
• Most active infectives dealmakers

The Infectives Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the infectives partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter infectives partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors infectives technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This report contains over 2,000 links to online copies of actual infectives deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

Get your copy of this report @ http://www.reportsnreports.com/reports/175335-infectives-partnering-terms-and-agreements.html

Report Details:
Published: July 2012
No. of Pages: 804
Price: US$ 3695



The initial chapters of this report provide an orientation of infectives dealmaking and business activities. Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in infectives dealmaking since 2007 covering trends by year, deal type, stage of development, technology type and therapeutic indication. In addition the chapter includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. Analysis includes median values and distribution of values for each stage of development.

Chapter 3 provides a review of the leading infectives deals since 2007. Deals are listed by headline value, signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of infectives deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Chapter 5 provides comprehensive access to all infectives deals since 2007 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all infectives partnering deals signed and announced since 2007. The chapter is organized by specific infectives therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all infectives partnering deals signed and announced since 2007. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in infectives partnering and dealmaking since 2007.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of infectives technologies and products.

Report scope

Infectives Partnering Terms and Agreements is intended to provide the reader with an in-depth understanding and access to infectives trends and structure of deals entered into by leading companies worldwide.

• Infectives Partnering Terms and Agreements includes:
• Trends in infectives dealmaking in the biopharma industry since 2007
• Analysis of infectives deal structure
• Access to headline, upfront, milestone and royalty data
• Access to hundreds of infectives deal contract documents
• Comprehensive access to over 2,000 infectives deal records
• The leading infectives deals by value since 2007
• Most active infectives dealmakers since 2007

In Infectives Partnering Terms and Agreements, available deals and contracts are listed by:

• Headline value
• Upfront payment value
• Royalty rate value
• Stage of development at signing
• Deal component type
• Technology type
• Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Infectives Partnering Terms and Agreements report provides comprehensive access to available deals and contract documents for over 2,000 infectives deals. Analyzing actual contract agreements allows assessment of the following:

• What are the precise infectives rights granted or optioned?
• What is actually granted by the agreement to the partner company?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How aresalesand payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are IPRs handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes to be resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Infectives Partnering Terms and Agreements provides the reader with the following key benefits:

• In-depth understanding of infectives deal trends since 2007
• Access infectives deal headline, upfront, milestone and royalty data
• Research hundreds of actual contracts between infectives partner companies
• Comprehensive access to over 2,000 links to actual infectives deals entered into by the world’s biopharma companies
• Indepth review of infectives deals entered into by the leading fifty bigpharma companies
• Benchmark the key deal terms companies have agreed in previous deals
• Identify key terms under which companies partner infectives opportunities
• Uncover companies actively partnering infectives opportunities

Pharmacy Retailing Industry in the UK

With an ageing population, significant changes in government policy and consolidation in the market, Pharmacy is an ever-changing sector. Learn where the opportunities and threats are in the market and how to manage these most effectively for your business.

Features and Benefits

• Reduce the impact of changes in government policy on your business by being prepared and understanding where the greatest threats will come from.
• Use the data, forecasts to 2015, and insight on the market, including NHS receipts and OTC, to help form an effective growth strategy.
• Understand the impact on pharmacy retailing of the Boots/Walgreens merger and how the investment will increase competitiveness in the sector.
• Identify the opportunities to grow business in this sector by comparing strategies of the key players in the market and their performance metrics.

Buy your copy of this report @ http://www.reportsnreports.com/reports/174249-pharmacy-retailing-in-the-uk.html

Report Details:

Published: July 2012
No. of Pages: 149

Price: Single User License – US$5250              Corporate User License – US$13125

Highlights

In 2011, the government announced plans for changes in the control of entry rules that would end the 100 hours exemption and this has prompted a rush of opening applications which we forecast will dilute profitability. 250 new pharmacies opened in the first four months of 2012.

Furthermore price deflation is making the pharmacy model non viable. Cost per prescription has fallen 23.0% since 2004 as the government has reduced reimbursement rates. This, combined with imminent patent expirations, will lower prices further.

The takeover of Alliance Boots by the largest pharmacy chain in the United States, Walgreens, expected to be completed before 2016, will lead to a major reinforcement of Boots’ existing economies of scale. The new group will have 11,000 stores in 12 countries and is expected to have a turnover of $130.0bn (£82.6bn) by 2016

Your key questions answered

• What impact is deflation and government strategy having on the market and how can this be managed to ensure success?
• How are grocers and local GPs threatening pharmacy specialists and how can retailers deal with these threats and increase customer loyalty?
• Which retailers will gain market share in 2012, which are expected to be the greatest share losers and why? What can competitors learn from this?
• What are the factors that will impede or maximise future growth opportunities and sales in pharmacy retailing?

United States Market for Ankylosing Spondylitis Pharmacotherapy

This research service covers the United States market for ankylosing spondylitis pharmaceuticals market from 2009 to 2017, with 2011 as the base year. The focus of this research is on biologics and other treatments prescribed as add-on therapies; background standard of care therapies are not covered in this study. Included in the study are products on the market and products in development as well as patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed. The market is segmented by classes of drug: tumor necrosis factor (TNF) inhibitors and non-TNF biologics.


Buy your copy of this report @ http://www.reportsnreports.com/reports/174278-united-states-market-for-ankylosing-spondylitis-pharmacotherapy.html

Report Details:

Published: July 2012
No. of Pages: 85

Price: US$6000

Major points covered in Table of Contents of this report include:

Executive Summary

Market Overview

Total Ankylosing Spondylitis Pharmacotherapeutics Market

• External Challenges: Drivers and Restraints
• Forecasts and Trends
• Demand Analysis
• Market Share and Competitive Analysis

TNF Inhibitor Segment Breakdown

Non-TNF Biologics Segment Breakdown

The Last Word (Conclusions and Implications)

Appendix

Russian Cement Industry Outlook: Business Opportunities and Future Growth Potential to 2016

The Russian cement market follows the trend of the country’s construction market, during both the review and forecast periods. The cement market recorded a significant reduction in production and demand when the global financial crisis hit the Russian economy from late 2008 onwards. Many impending construction projects were suspended, and the cement market was adversely affected. The cement industry in Russia grew at a CAGR of 6.70% during the review period. During the review period, the cement clinker category was the largest cement type and accounted for 34.5% of the total cement industry. The growth is primarily attributed to the government’s spending on infrastructure and the growing residential and commercial construction market. Wet cement manufacturing is the dominant production process for cement in Russia. Most plants in Russia are dated and in need of modernization, and the wet process also involves substantial energy input. Most new companies setting up plants in Russia are therefore opting for dry process plants. The Russian cement market comprises more than 50 cement manufacturers. The largest companies in the industry include JSC Eurocement Group, Sibirsky Cement, Lafarge, Alpha-Cement (a subsidiary of Holcim), Novorosstcement and the Park Group.

Scope

• This report provides a comprehensive analysis of the Russian cement industry
• It provides historical values for the Russian cement industry for the report’s 2007–2011 review period and forecast figures for the 2012–2016 forecast period
• It offers a detailed analysis of production capacity, consumption, imports and exports of cement
• It details the regulatory framework for the Russian cement industry
• It covers an exhaustive summary of the key trends, drivers and issues affecting the Russian cement industry
• It details the competitive landscape in the Russian cement industry
• Analysis of market entry, growth and operational strategies of key players

Buy your copy of this report @http://www.reportsnreports.com/reports/172691-russian-cement-industry-outlook-business-opportunities-and-future-growth-potential-to-2016.html

Report Details:

Published: June 2012
No. of Pages: 61

Price: Single User License – US$1950              Corporate User License – US$5850

Key highlights

• During the review period, the cement clinker category was the largest cement type and accounted for 34.5% of the total cement industry
• Factory-made mortars is projected to be the fastest-growing category over the forecast period with a CAGR of 8.68%
• Cement clinker will continue to be the largest cement category over the forecast period, followed by ready-mixed concrete
• The construction boom has led to heavy use of electricity for cement production in the country. To cater to this demand, companies have been using technological support to enhance productivity and ensure a continuous supply of electricity
• Production in almost all cement plants across the country increased in 2011. Some of the new plants that were launched in 2011 include the YUUGPK factory in the Urals and the LSR-CT plant (a subsidiary of LSR Group) in the Saint Petersburg region

Reasons to buy

• Make strategic business decisions using historic and forecast market data related to the Russian cement industry
• Assess the growth opportunities and industry dynamics by understanding production capacity, demand, imports and exports figures
• Identify the key market trends and opportunities
• Assess the competitive landscape in the Russian cement industry enabling the formulation of effective market-entry strategies

Diabetic Foot Ulcer Therapeutics Market Forecasts to 2019

The report provides information on the key drivers and challenges of the Diabetic Foot Ulcers Therapeutics market. Its scope includes - 
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Diabetic Foot Ulcers Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. 
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Diabetic Foot Ulcers Therapeutics market. 
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. 
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Diabetic Foot Ulcers Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Diabetic Foot Ulcers Therapeutics market 

Reasons to buy

The report will enhance your decision making capability. It will allow you to - 
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. 
- Develop business strategies by understanding the trends shaping and driving the global Diabetic Foot Ulcers Therapeutics market. 
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Diabetic Foot Ulcers Therapeutics market in future. 
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. 
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. 
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. 
- What’s the next big thing in the global Diabetic Foot Ulcers Therapeutics market landscape? – Identify, understand and capitalize.


Buy your copy of this report @ http://www.reportsnreports.com/reports/174216-diabetic-foot-ulcer-therapeutics-pipeline-assessment-and-market-forecasts-to-2019.html

Report Details:

Published: July 2012
No. of Pages: 96

Price: Single User License – US$3995              Corporate User License – US$11985

List of Figures
Figure 1: The University of Texas - Diabetic Wound Classification System 9
Figure 2: Diabetic Foot Ulcer - Pathophysiology 14
Figure 3: Diabetic Foot Infections - Antibiotic Use According to Clinical Severity 16
Figure 4: Diabetic Foot Ulcer - Referral Pathway 17
Figure 5: Diabetic Foot Infection Therapeutics Market, Global, Revenue ($m), 2006-2011 19
Figure 6: Wound-healing Therapeutics Market, Global, Revenue ($m), 2006-2011 20
Figure 7: Diabetic Foot Infection Therapeutics Market, Global, Forecast ($m), 2011-2019 21
Figure 8: Wound-healing Therapeutics Market, Global, Forecast ($m), 2011-2019 22
Figure 9: Diabetic Foot Infection Therapeutics Market, The US, Revenue ($m), 2006-2011 23
Figure 10: Wound-healing Therapeutics Market, The US, Revenue ($m), 2006-2011 24
Figure 11: Diabetic Foot Infection Therapeutics Market, The US, Forecast ($m), 2011-2019 25
Figure 12: Wound-healing Therapeutics Market, The US, Forecast ($m), 2011-2019 26
Figure 13: Diabetic Foot Infection Therapeutics Market, France, Revenue ($m), 2006-2011 27
Figure 14: Wound-healing Therapeutics Market, France, Revenue ($m), 2006-2011 28
Figure 15: Diabetic Foot Infection Therapeutics Market, France, Forecast ($m), 2011-2019 29
Figure 16: Wound-healing Therapeutics Market, France, Forecast ($m), 2011-2019 30
Figure 17: Diabetic Foot Infection Therapeutics Market, Germany, Revenue ($m), 2006-2011 31
Figure 18: Wound-healing Therapeutics Market, Germany, Revenue ($m), 2006-2011 32
Figure 19: Diabetic Foot Infection Therapeutics Market, Germany, Forecast ($m), 2011-2019 33
Figure 20: Wound-healing Therapeutics Market, Germany, Forecast ($m), 2011-2019 34
Figure 21: Diabetic Foot Infection Therapeutics Market, Italy, Revenue ($m), 2006-2011 35
Figure 22: Wound-healing Therapeutics Market, Italy, Revenue ($m), 2006-2011 36
Figure 23: Diabetic Foot Infection Therapeutics Market, Italy, Forecast ($m), 2011-2019 37
Figure 24: Wound-healing Therapeutics Market, Italy, Forecast ($m), 2011-2019 38
Figure 25: Diabetic Foot Infection Therapeutics Market, Spain, Revenue ($m), 2006-2011 39
Figure 26: Wound-healing Therapeutics Market, Spain, Revenue ($m), 2006-2011 40
Figure 27: Diabetic Foot Infection Therapeutics Market, Spain, Forecast ($m), 2011-2019 41
Figure 28: Wound-healing Therapeutics Market, Spain, Forecast ($m), 2011-2019 42
Figure 29: Diabetic Foot Infection Therapeutics Market, The UK, Revenue ($m), 2006-2011 43
Figure 30: Wound-healing Therapeutics Market, The UK, Revenue ($m), 2006-2011 44
Figure 31: Diabetic Foot Infection Therapeutics Market, The UK, Forecast ($m), 2011-2019 45
Figure 32: Wound-healing Therapeutics Market, The UK, Forecast ($m), 2011-2019 46
Figure 33: Diabetic Foot Infection Therapeutics Market, Japan, Revenue ($m), 2006-2011 47
Figure 34: Wound-healing Therapeutics Market, Japan, Revenue ($m), 2006-2011 48
Figure 35: Diabetic Foot Infection Therapeutics Market, Japan, Forecast ($m), 2011-2019 49
Figure 36: Wound-healing Therapeutics Market, Japan, Forecast ($m), 2011-2019 50
Figure 37: Diabetic Foot Ulcer Therapeutics Market, Drivers and Barriers, 2012 52
Figure 38: Opportunity and Unmet Need in Diabetic Foot Infection Therapeutics Market, 2012 53
Figure 39: Opportunity and Unmet Need in the Diabetic Foot Ulcer Wound-healing Therapeutics Market, 2012 54
Figure 40: Strategic Competitor Assessment of the Marketed Products in Diabetic Foot Ulcer Therapeutics, 2012 56
Figure 41: Diabetic Foot Ulcer Therapeutics, Clinical Pipeline by Mechanism of Action (%), 2012 65
Figure 42: Diabetic Foot Ulcer Therapeutics, Clinical Pipeline by Phase of Development (%), 2012 66
Figure 43: Technology Trends Analytics Framework, 2012 67
Figure 44: Technology Trends Analytics Framework - Description, 2012 68
Figure 45: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials by Country, 2012 72
Figure 46: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials by Phase (%), 2012 73
Figure 47: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials by Status of Development (%), 2012 74
Figure 48: Diabetic Foot Ulcer Therapeutics, Global, Overall Sponsors (%), 2012 75
Figure 49: Diabetic Foot Ulcer Therapeutics, Global, Prominent Sponsors (%), 2012 76
Figure 50: Diabetic Foot Ulcer Therapeutics, Global, Top Companies by Phase, 2012 77
Figure 51: Diabetic Foot Ulcer Therapeutics Market, Impact Analysis, 2012 78
Figure 52: Implications for Future Market Competition in the Diabetic Foot Ulcer Therapeutics Market, 2012 79
Figure 53: Diabetic Foot Ulcer Therapeutics, Clinical Pipeline by Company, 2012 81
Figure 54: GlobalData Market Size Estimation 93
Figure 55: GlobalData Market Forecasting Model 95